 Dulcy Wolverton
Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammography | 11 | 2024 | 146 | 0.910 |
Why?
| | Breast Neoplasms | 15 | 2024 | 2131 | 0.590 |
Why?
| | Health Literacy | 2 | 2024 | 161 | 0.360 |
Why?
| | Carcinoma, Intraductal, Noninfiltrating | 3 | 2017 | 54 | 0.290 |
Why?
| | Communication | 2 | 2023 | 838 | 0.270 |
Why?
| | Comprehension | 2 | 2024 | 165 | 0.220 |
Why?
| | Chemotherapy, Adjuvant | 3 | 2021 | 377 | 0.220 |
Why?
| | Patients | 1 | 2023 | 167 | 0.190 |
Why?
| | Image Enhancement | 2 | 2021 | 163 | 0.190 |
Why?
| | Neoadjuvant Therapy | 2 | 2021 | 381 | 0.170 |
Why?
| | Mastectomy | 2 | 2020 | 131 | 0.170 |
Why?
| | Radiology | 2 | 2021 | 161 | 0.170 |
Why?
| | Contrast Media | 2 | 2021 | 387 | 0.160 |
Why?
| | Delayed Diagnosis | 1 | 2020 | 79 | 0.160 |
Why?
| | Magnetic Resonance Imaging | 5 | 2021 | 3371 | 0.160 |
Why?
| | Patient Education as Topic | 1 | 2024 | 733 | 0.160 |
Why?
| | Early Detection of Cancer | 1 | 2023 | 369 | 0.160 |
Why?
| | Aromatase Inhibitors | 1 | 2017 | 51 | 0.140 |
Why?
| | Patient Care Management | 1 | 2017 | 56 | 0.140 |
Why?
| | Breast | 2 | 2021 | 152 | 0.100 |
Why?
| | Breast Diseases | 2 | 2000 | 22 | 0.080 |
Why?
| | Aged | 8 | 2024 | 21892 | 0.080 |
Why?
| | Receptors, Estrogen | 1 | 2011 | 424 | 0.080 |
Why?
| | Middle Aged | 11 | 2024 | 30812 | 0.070 |
Why?
| | Humans | 21 | 2024 | 128019 | 0.070 |
Why?
| | Female | 16 | 2024 | 68016 | 0.070 |
Why?
| | Surveys and Questionnaires | 3 | 2024 | 5353 | 0.060 |
Why?
| | Fibroadenoma | 1 | 2005 | 2 | 0.060 |
Why?
| | Phyllodes Tumor | 1 | 2005 | 2 | 0.060 |
Why?
| | Carcinoma, Ductal | 1 | 2005 | 11 | 0.060 |
Why?
| | Spectrum Analysis | 1 | 2005 | 86 | 0.060 |
Why?
| | Patient Portals | 1 | 2024 | 42 | 0.060 |
Why?
| | Adult | 8 | 2024 | 35176 | 0.050 |
Why?
| | Neoplasms | 1 | 2018 | 2460 | 0.050 |
Why?
| | Patient Navigation | 1 | 2024 | 79 | 0.050 |
Why?
| | Genetic Carrier Screening | 1 | 2002 | 25 | 0.050 |
Why?
| | BRCA2 Protein | 1 | 2002 | 53 | 0.050 |
Why?
| | BRCA1 Protein | 1 | 2002 | 65 | 0.050 |
Why?
| | Germ-Line Mutation | 1 | 2002 | 138 | 0.050 |
Why?
| | Electronics | 1 | 2021 | 73 | 0.050 |
Why?
| | Specialization | 1 | 2002 | 144 | 0.050 |
Why?
| | Medical Oncology | 1 | 2023 | 271 | 0.050 |
Why?
| | Neoplasm Staging | 3 | 2017 | 1288 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2024 | 860 | 0.040 |
Why?
| | Patient Participation | 1 | 2024 | 409 | 0.040 |
Why?
| | Medicine | 1 | 2002 | 117 | 0.040 |
Why?
| | Radiographic Image Enhancement | 1 | 2000 | 52 | 0.040 |
Why?
| | Internet | 1 | 2024 | 613 | 0.040 |
Why?
| | Educational Status | 1 | 2022 | 470 | 0.040 |
Why?
| | Family Practice | 1 | 2023 | 434 | 0.040 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2002 | 734 | 0.040 |
Why?
| | Biopsy | 2 | 2017 | 1077 | 0.040 |
Why?
| | Health Personnel | 1 | 2023 | 645 | 0.030 |
Why?
| | Patient-Centered Care | 1 | 2022 | 493 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2024 | 973 | 0.030 |
Why?
| | Cohort Studies | 2 | 2021 | 5378 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2005 | 1558 | 0.030 |
Why?
| | Qualitative Research | 1 | 2023 | 1224 | 0.030 |
Why?
| | Databases, Factual | 2 | 2018 | 1264 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2017 | 283 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2021 | 724 | 0.030 |
Why?
| | Treatment Outcome | 3 | 2021 | 10110 | 0.030 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 1996 | 96 | 0.030 |
Why?
| | Clinical Competence | 1 | 2002 | 1007 | 0.030 |
Why?
| | Medicare | 1 | 2020 | 715 | 0.030 |
Why?
| | Prognosis | 2 | 2017 | 3766 | 0.030 |
Why?
| | Calcinosis | 1 | 1996 | 230 | 0.030 |
Why?
| | Software | 1 | 2018 | 606 | 0.030 |
Why?
| | Mass Screening | 1 | 2000 | 1145 | 0.030 |
Why?
| | Biopsy, Needle | 2 | 2005 | 187 | 0.030 |
Why?
| | Immunohistochemistry | 2 | 2006 | 1663 | 0.020 |
Why?
| | Diagnosis, Differential | 3 | 2002 | 1408 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2005 | 7029 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2021 | 14404 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2011 | 1199 | 0.020 |
Why?
| | ROC Curve | 2 | 2002 | 500 | 0.020 |
Why?
| | Sensitivity and Specificity | 2 | 2005 | 1813 | 0.020 |
Why?
| | Antigens, CD34 | 1 | 2006 | 89 | 0.020 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2006 | 59 | 0.020 |
Why?
| | Ki-67 Antigen | 1 | 2006 | 107 | 0.020 |
Why?
| | Subtraction Technique | 1 | 2005 | 23 | 0.020 |
Why?
| | Gadolinium DTPA | 1 | 2005 | 49 | 0.020 |
Why?
| | Young Adult | 1 | 2021 | 12281 | 0.010 |
Why?
| | Lasers | 1 | 2005 | 132 | 0.010 |
Why?
| | Prospective Studies | 1 | 1996 | 7035 | 0.010 |
Why?
| | Radiography | 1 | 2006 | 794 | 0.010 |
Why?
| | Antigens, CD | 1 | 2006 | 481 | 0.010 |
Why?
| | United States | 1 | 2020 | 13785 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2011 | 4853 | 0.010 |
Why?
| | Biomarkers, Tumor | 1 | 2006 | 1175 | 0.010 |
Why?
| | Physical Examination | 1 | 2000 | 230 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2005 | 3009 | 0.010 |
Why?
| | Inflammation | 1 | 2006 | 2646 | 0.010 |
Why?
| | Algorithms | 1 | 2002 | 1609 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2002 | 2261 | 0.010 |
Why?
| | Risk Factors | 1 | 2002 | 9696 | 0.000 |
Why?
| | Adolescent | 1 | 2005 | 20158 | 0.000 |
Why?
|
|
Wolverton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|